Pharmaceutical compositions of pyrimidine-2,4,6-triones

Details Pharmaceutical compositions of pyrimidine-2,4,6-triones Pharmaceutical compositions of pyrimidine-2,4,6-triones

2009-05-27

2011-10-25

Maier, Leigh (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S270000

Reexamination Certificate

active

08044035

ABSTRACT:
A trioxopyrimidine-cyclodextrin complex formed of a trioxopyrimidine derivative or a salt thereof and a water-soluble cyclodextrin derivative has improved solubility.

REFERENCES:
patent: 6110924 (2000-08-01), Bosies et al.
patent: 6242455 (2001-06-01), Grams et al.
patent: 6350786 (2002-02-01), Albano et al.
patent: 1 018 340 (2000-07-01), None
patent: WO 97/23465 (1997-07-01), None
patent: WO 98/58915 (1998-12-01), None
patent: WO 00/37109 (2000-06-01), None
patent: WO 00/40962 (2000-07-01), None
patent: WO 01/25217 (2001-04-01), None
patent: WO 02/089824 (2002-11-01), None
patent: WO 2005/097058 (2005-10-01), None
Szente, L. et al “Highly soluble cyclodextrin derivatives . . . ” Adv. Drug Deliv. Rev. (1999) vol. 36, pp. 17-28.
Egeblad, M., and Werb, Z., Nat. Rev. Cancer 2 (2002) 161-174.
Overall, C.M., and Lopez-Otin, C., Nat. Rev. Cancer 2 (2002) 657-672.
Holmbeck, K., et al., Cell 99 (1999) 81-92.
Vu, T.H., et al., Cell 93 (1998) 411-422.
Shapiro, S.D., Curr. Opin. Cell Biol. 10 (1998) 602-608.
Lund, L.R., et al., EMBO J. 18 (1999) 4645-4656.
Carmeliet, P., et al., Nat. Genet. 17 (1997) 439-444.
Chang, C., and Werb, D., Trends Cell Biol. 11 (2001) S37-43.
Manes, S., et al., J. Biol. Chem. 274 (1999) 6935-6945.
Bergers, G., et al., Nat. Cell Biol. 2 (2000) 737-744.
Dong, Z., et al., Cell 88 (1997) 801-810.
Janowska-Wieczorek, A., et al., Blood 93 (1999) 3379-3390.
Carstanjen, D., et al., Transfusion 42 (2002) 588-596.
Grams, F., et al., Biol. Chem. 382 (2001) 1277-1285.
Ansel, H., et. al., Pharmaceutical Dosage Forms and Drug Delivery Systems, 6th ed., (1995), pp. 196 and 1456-1457.
Fabbri, L.M., and Hurd, S.S., Eur. Respir. J. 22 (2003) 1-2.
Higuchi, T., and Connors, K.A., Advances in Analytical Chemistry and Instrumentation 4 (1965) 117-212.
Yu, Z., and Westerlund, D., Chromatographia 44 (1997) 589-594.
Hubert, Ph., et al., S. T. P. Pharma Pratiques 9 (1999) 160-180.
Souverain, S., et al., Journal of Chromatography B 801 (2004) 141-156).
Chiap, P., et al., Journal of Chromatography B 817 (2005), 109-117.
Hubert, P., et al., Analytica Chimica Acta 391 (1999) 135-148.
Hubert, Ph., et al., S. T. P. Pharma Pratiques 13 (2003) 27-64.
Hubert, Ph., et al., J. Pharm. Biomed. Anal. 36 (2004) 579-586.
Hamelmann, E., et al., Am. J Respir. Crit. Care Med. 156 (1997) 766-775.
Cataldo, D.D., et al, Am. J. Pathol. 161 (2002) 491-498.
Aki,e t. al. Jour of Pharm Sci, V. 90 (2001) 1186-1197.
Csabai, Int Jour of Pharm 91 (1993) 15-22.
Foley, Bio & Med Chem Ltr (2001) 969-972.
Lopata, Jour of Phar Sci, 74 (1985) 211-213.
Mura, Eur Jour of Pharm (2005) 99-106.
Piel, Jour of Pharm Sci, 86 (1997) 475-480.
Szejtli, Cyclodextrin Tech (1988) 186-307.
Iwaoku, Chem Pharm Bull (1982) 1416-1421.
Loukas, Int Jour of Pharm 226 (2001) 207-211.
Suzuki, Chem Pharm Bull (1993) 1444-1447.
Lein, Oncogene (2002) 2089-2096.
Mura, Int Jour Pharm 260 (2003) 293-302.
Kumagai et al,The Jour. of Immunology, (1999) 162: 4212-4219.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions of pyrimidine-2,4,6-triones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions of pyrimidine-2,4,6-triones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions of pyrimidine-2,4,6-triones will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4300495